My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Board of PTL Enterprises recommends final dividend
May 05,2017

PTL Enterprises announced that the Board of Directors of the Company at its meeting held on 4 May 2017, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 62.5%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

RDB Rasayans commissions 540 kWp Roof Top Solar Power Plant
May 05,2017

RDB Rasayans has installed and commissioned 540 kWp Roof Top Solar Power Plant at its factory premises situated at Haldia, West Bengal.

Powered by Capital Market - Live News

eVIN Project of Health Ministry becomes global best practise in immunisation
May 05,2017

Members of a five country international delegation called on Shri C K Mishra, Secretary Ministry of Health & Family Welfare. They interacted with the Health Secretary to learn more about the global best practice of eVIN (electronic vaccine intelligence network) project of the Health Ministry and to understand how it is being implemented in the country and the ways in which it be replicated in their own countries.

Shri Mishra said that the Ministry is ready to provide support and collaborate with other countries to strengthen their capacities and scale up their programs. He also stated that this is a big boost for the Digital India and Make in India initiatives of the Government. This sets a benchmark in the field of immunisation, he said. The delegation shared the experience from their countries of the immunisation projects, and expressed the shared view that the India visit shall enrich them to strengthen their own country programs.

Stating that India has a lot to share in terms of best practices and new learning, Mr. Jaco Cilliers, Country Director, UNDP stated that such visits provide an opportunity to other countries to learn from these best practices of India in the field of immunisation and strengthen their own programs.

Dr. Rakesh Kumar, Addl. Country Director, UNDP stated that while the country is working towards enhancing the coverage of immunisation, quality of vaccines through maintenance of the right temperature is also a critical component to for the quality and efficacy of the vaccines. eVIN is a step towards ensuring that, he stated.

eVIN (Electronic Vaccine Intelligence Network) is an indigenously developed technology system in India that digitizes vaccine stocks and monitors the temperature of the cold chain through a smartphone application. The innovative eVIN is presently being implemented called across twelve states in India. eVIN aims to support the Government of Indias Universal Immunization Programme by providing real-time information on vaccine stocks and flows, and storage temperatures across all cold chain points in these states. The technological innovation is implemented by the United Nations Development Programme (UNDP).

eVIN aims to strengthen the evidence base for improved policy-making in vaccine delivery, procurement and planning for new antigens in India. eVIN provides an integrated solution to address widespread inequities in vaccine coverage by supporting state governments in overcoming constraints of infrastructure, monitoring and management information systems and human resources, often resulting in overstocking and stock-outs of vaccines in storage centres.

The integrated solution combines:

n++Technology: to facilitate evidence-based decision-making by making available online real-time information on vaccine stocks and storage temperature through the eVIN application software and temperature loggers;

n++Governance: to ensure efficient vaccine logistics management by systemizing record keeping through standardizing stock and distribution registers; identifying gaps and improving clarity on vaccine cold chain network; drawing attention to infrastructure upgrades; developing standard operating procedures; and encouraging good practices;

n++Human Resources: to empower the state cold chain network by building the capacities of government cold chain handlers; and deploying vaccine and cold chain managers in every district for constant support to estimate vaccine requirements, supervise cold chain handlers and coordinate with cold chain technicians across the district.

eVIN empowers the cold chain handlers by building technical capacities and providing a robust decision-making tool for cold chain managers through a complete overview of vaccine replenishment times, supply and consumption patterns.

By streamlining the vaccine flow network, eVIN is a powerful contribution to strengthening health systems and ensures equity through easy and timely availability of vaccines to all children.

Powered by Capital Market - Live News

Tata Communications leads losers in A group
May 05,2017

Tata Communications lost 8.81% to Rs 642.65 at 13:12 IST. The stock topped the losers in the BSEs A group. On the BSE, 4.21 lakh shares were traded on the counter so far as against the average daily volumes of 64,000 shares in the past two weeks. Tata Communications reported consolidated net loss of Rs 260.81 crore in Q4 March 2017, higher than net loss of Rs 256.95 crore in Q4 March 2016. Total income rose 7.64% to Rs 5116.48 crore in Q4 March 2017 over Q4 March 2016. The announcement was made after market hours yesterday, 4 May 2017.

Hindustan Construction Company dropped 7% to Rs 43.20. The stock was the second biggest loser in A group. On the BSE, 23.10 lakh shares were traded on the counter so far as against the average daily volumes of 20.36 lakh shares in the past two weeks. Hindustan Construction Companys net profit declined 4.13% to Rs 20.91 crore on 13.57% rise in net sales to Rs 1358.27 crore in Q4 March 2017 over Q4 March 2016. The result was announced after market hours yesterday, 4 May 2017.

Vedanta fell 5.68% at Rs 219.25. The stock was the third biggest loser in A group. On the BSE, 14.43 lakh shares were traded on the counter so far as against the average daily volumes of 11.41 lakh shares in the past two weeks.

Amtek Auto declined 4.44% at Rs 37.65. The stock was the fourth biggest loser in A group. On the BSE, 3.73 lakh shares were traded on the counter so far as against the average daily volumes of 17.16 lakh shares in the past two weeks.

Jindal Steel & Power slipped 4.92% to Rs 107.25. The stock was the fifth biggest loser in A group. On the BSE, 16.81 lakh shares were traded on the counter so far as against the average daily volumes of 15.87 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Bitter pill for Wockhardt after dismal Q4 result
May 05,2017

The result was announced after market hours yesterday, 4 May 2017.

Meanwhile, the S&P BSE Sensex was down 208.45 points, or 0.69% to 29,917.76. The S&P BSE Mid-Cap index was down 97.57 points, or 0.66% to 14,783.27.

On the BSE, 1.68 lakh shares were traded in the counter so far, compared with average daily volumes of 4.29 lakh shares in the past one quarter. The stock had hit a high of Rs 697.35 and a low of Rs 683.60 so far during the day. The stock hit a 52-week high of Rs 1,129 on 21 July 2016. The stock hit a 52-week low of Rs 627 on 27 December 2016.

The mid-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

Wockhardts consolidated total income fell 10.53% to Rs 919.82 crore in Q4 March 2017 over Q4 March 2016.

On a consolidated basis, Wockhardts earnings before interest, taxation, depreciation and amortization (EBITDA) loss was Rs 177 crore in Q4 March 2017 as against the EBITDA profit of Rs 72 crore in Q4 March 2016.

Wockhardt said that during the year, certain polito-economic issues beyond the control of the company like Brexit in UK and consequent volatility in various currencies like GBP, INR, Euro, demonetisation in India and ongoing US FDA related matters had adversely affected the revenue growth. Whereas the company had a n++one time opportunityn++ of business in UK in the previous year, growth in UK in the current year remained subdued due to such polito-economic adversities.

In USA, genercisation of some of the products of the company also impacted business. While clear focus on cost containments and rationalisation gave positive impact, on-going expenses on remedial measures (for US FDA related issues) impacted the profitability. The companys performance during the quarter was affected by subdued business in US & UK market, continued impact on account of Brexit and remediation costs.

Wockhardts UK business in GBP terms excluding one time opportunity grew by 8% in the year ended 31 March 2017 (FY 2017) compared to FY 2016. The company made 7 new fillings and received 3 new approvals in UK market in FY 2017.

Wockhardts India business grew by 6% in FY 2017. 24 new products were launched in FY 2017 in line with focused strategies on various therapies and new products launches. India business during Q4 March 2017 de-grew by 4% in comparison to Q4 March 2016 mainly on account of demonetisation.

Emerging market business of the company continued to grow by 15% in Q4 March 2017 compared to Q4 March 2016. International business contributed 62% of the total revenues during the Q4 March 2017.

Meanwhile, the board of directors of the company has approved raising of additional capital by way of one or more public or private offerings including through a Qualified Institutions Placement (QIP) to eligible investors through an issuance of equity shares or other eligible securities for an amount not exceeding Rs 1000 crore.

Wockhardt is a global pharmaceutical and biotech company with presence in USA, UK, Ireland, Mexico, Russia and many other countries. It has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland. Wockhardt has a significant presence in USA, Europe and India, with 62% of its global revenues coming from international businesses.

Powered by Capital Market - Live News

Gallantt Ispat standalone net profit rises 75.67% in the March 2017 quarter
May 05,2017

Net profit of Gallantt Ispat rose 75.67% to Rs 7.22 crore in the quarter ended March 2017 as against Rs 4.11 crore during the previous quarter ended March 2016. Sales declined 31.22% to Rs 100.26 crore in the quarter ended March 2017 as against Rs 145.77 crore during the previous quarter ended March 2016.

For the full year,net profit rose 54.77% to Rs 44.25 crore in the year ended March 2017 as against Rs 28.59 crore during the previous year ended March 2016. Sales declined 20.58% to Rs 424.71 crore in the year ended March 2017 as against Rs 534.76 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales100.26145.77 -31 424.71534.76 -21 OPM %12.907.65 -12.439.83 - PBDT11.078.28 34 48.5544.93 8 PBT8.174.95 65 36.1431.02 17 NP7.224.11 76 44.2528.59 55

Powered by Capital Market - Live News

Multi Commodity Exchange of India standalone net profit declines 50.78% in the March 2017 quarter
May 05,2017

Net profit of Multi Commodity Exchange of India declined 50.78% to Rs 21.88 crore in the quarter ended March 2017 as against Rs 44.45 crore during the previous quarter ended March 2016. Sales rose 3.20% to Rs 57.38 crore in the quarter ended March 2017 as against Rs 55.60 crore during the previous quarter ended March 2016.

For the full year,net profit rose 10.98% to Rs 126.27 crore in the year ended March 2017 as against Rs 113.78 crore during the previous year ended March 2016. Sales rose 11.74% to Rs 238.60 crore in the year ended March 2017 as against Rs 213.53 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales57.3855.60 3 238.60213.53 12 OPM %22.8832.97 -33.4335.26 - PBDT37.3765.65 -43 195.99191.46 2 PBT32.4660.20 -46 177.42166.87 6 NP21.8844.45 -51 126.27113.78 11

Powered by Capital Market - Live News

Tata Communications reports standalone net loss of Rs 1264.86 crore in the March 2017 quarter
May 05,2017

Net loss of Tata Communications reported to Rs 1264.86 crore in the quarter ended March 2017 as against net profit of Rs 86.93 crore during the previous quarter ended March 2016. Sales rose 4.78% to Rs 1280.49 crore in the quarter ended March 2017 as against Rs 1222.13 crore during the previous quarter ended March 2016.

For the full year,net profit rose 75.67% to Rs 689.83 crore in the year ended March 2017 as against Rs 392.68 crore during the previous year ended March 2016. Sales rose 5.80% to Rs 5068.15 crore in the year ended March 2017 as against Rs 4790.32 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1280.491222.13 5 5068.154790.32 6 OPM %19.7526.87 -23.5424.89 - PBDT-368.49370.22 PL 1145.601370.56 -16 PBT-566.05180.95 PL 381.02627.57 -39 NP-1264.8686.93 PL 689.83392.68 76

Powered by Capital Market - Live News

Oberoi Realty standalone net profit declines 27.07% in the March 2017 quarter
May 05,2017

Net profit of Oberoi Realty declined 27.07% to Rs 85.88 crore in the quarter ended March 2017 as against Rs 117.75 crore during the previous quarter ended March 2016. Sales rose 35.80% to Rs 234.01 crore in the quarter ended March 2017 as against Rs 172.32 crore during the previous quarter ended March 2016.

For the full year,net profit declined 35.56% to Rs 320.64 crore in the year ended March 2017 as against Rs 497.59 crore during the previous year ended March 2016. Sales declined 24.74% to Rs 890.59 crore in the year ended March 2017 as against Rs 1183.39 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales234.01172.32 36 890.591183.39 -25 OPM %52.3844.99 -51.8747.36 - PBDT135.24152.53 -11 518.12722.80 -28 PBT127.81142.08 -10 476.12680.73 -30 NP85.88117.75 -27 320.64497.59 -36

Powered by Capital Market - Live News

Astec Lifesciences standalone net profit rises 292.13% in the March 2017 quarter
May 05,2017

Net profit of Astec Lifesciences rose 292.13% to Rs 3.49 crore in the quarter ended March 2017 as against Rs 0.89 crore during the previous quarter ended March 2016. Sales rose 14.25% to Rs 88.28 crore in the quarter ended March 2017 as against Rs 77.27 crore during the previous quarter ended March 2016.

For the full year,net profit rose 5354.29% to Rs 19.09 crore in the year ended March 2017 as against Rs 0.35 crore during the previous year ended March 2016. Sales rose 36.55% to Rs 303.01 crore in the year ended March 2017 as against Rs 221.90 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales88.2877.27 14 303.01221.90 37 OPM %19.0018.62 -20.7113.85 - PBDT14.6011.77 24 52.8921.10 151 PBT10.188.55 19 39.2210.74 265 NP3.490.89 292 19.090.35 5354

Powered by Capital Market - Live News

Wockhardt reports standalone net loss of Rs 5.91 crore in the March 2017 quarter
May 05,2017

Net loss of Wockhardt reported to Rs 5.91 crore in the quarter ended March 2017 as against net profit of Rs 0.79 crore during the previous quarter ended March 2016. Sales rose 6.33% to Rs 540.54 crore in the quarter ended March 2017 as against Rs 508.34 crore during the previous quarter ended March 2016.

For the full year,net profit rose 1544.12% to Rs 137.12 crore in the year ended March 2017 as against Rs 8.34 crore during the previous year ended March 2016. Sales rose 3.65% to Rs 2297.52 crore in the year ended March 2017 as against Rs 2216.53 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales540.54508.34 6 2297.522216.53 4 OPM %9.261.84 -6.305.68 - PBDT26.92-10.96 LP 224.4479.56 182 PBT1.61-34.47 LP 118.78-19.52 LP NP-5.910.79 PL 137.128.34 1544

Powered by Capital Market - Live News

L&T Finance Holdings consolidated net profit rises 33.35% in the March 2017 quarter
May 05,2017

Net profit of L&T Finance Holdings rose 33.35% to Rs 315.83 crore in the quarter ended March 2017 as against Rs 236.85 crore during the previous quarter ended March 2016. Sales rose 10.45% to Rs 2162.56 crore in the quarter ended March 2017 as against Rs 1957.97 crore during the previous quarter ended March 2016.

For the full year,net profit rose 21.65% to Rs 1042.18 crore in the year ended March 2017 as against Rs 856.69 crore during the previous year ended March 2016. Sales rose 14.43% to Rs 8340.59 crore in the year ended March 2017 as against Rs 7288.79 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales2162.561957.97 10 8340.597288.79 14 OPM %54.6973.03 -66.4472.41 - PBDT100.29355.32 -72 1146.201335.47 -14 PBT85.34334.26 -74 1078.901252.66 -14 NP315.83236.85 33 1042.18856.69 22

Powered by Capital Market - Live News

Gallantt Metal standalone net profit declines 53.38% in the March 2017 quarter
May 05,2017

Net profit of Gallantt Metal declined 53.38% to Rs 5.52 crore in the quarter ended March 2017 as against Rs 11.84 crore during the previous quarter ended March 2016. Sales rose 3.73% to Rs 179.28 crore in the quarter ended March 2017 as against Rs 172.83 crore during the previous quarter ended March 2016.

For the full year,net profit declined 34.82% to Rs 27.10 crore in the year ended March 2017 as against Rs 41.58 crore during the previous year ended March 2016. Sales declined 7.95% to Rs 616.73 crore in the year ended March 2017 as against Rs 669.97 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales179.28172.83 4 616.73669.97 -8 OPM %7.6910.70 -8.6710.21 - PBDT11.2116.81 -33 47.1661.37 -23 PBT6.7812.60 -46 30.3143.82 -31 NP5.5211.84 -53 27.1041.58 -35

Powered by Capital Market - Live News

Larsen & Toubro Infotech standalone net profit declines 0.08% in the March 2017 quarter
May 05,2017

Net profit of Larsen & Toubro Infotech declined 0.08% to Rs 244.70 crore in the quarter ended March 2017 as against Rs 244.90 crore during the previous quarter ended March 2016. Sales rose 7.93% to Rs 1592.90 crore in the quarter ended March 2017 as against Rs 1475.80 crore during the previous quarter ended March 2016.

For the full year,net profit rose 9.51% to Rs 937.60 crore in the year ended March 2017 as against Rs 856.20 crore during the previous year ended March 2016. Sales rose 11.03% to Rs 6182.90 crore in the year ended March 2017 as against Rs 5568.50 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales1592.901475.80 8 6182.905568.50 11 OPM %17.6316.95 -17.7616.58 - PBDT333.60329.00 1 1293.101147.70 13 PBT308.80302.50 2 1184.201044.30 13 NP244.70244.90 0 937.60856.20 10

Powered by Capital Market - Live News

Emami standalone net profit declines 1.98% in the March 2017 quarter
May 05,2017

Net profit of Emami declined 1.98% to Rs 68.65 crore in the quarter ended March 2017 as against Rs 70.04 crore during the previous quarter ended March 2016. Sales declined 1.82% to Rs 527.54 crore in the quarter ended March 2017 as against Rs 537.32 crore during the previous quarter ended March 2016.

For the full year,net profit rose 4.28% to Rs 346.37 crore in the year ended March 2017 as against Rs 332.15 crore during the previous year ended March 2016. Sales rose 7.01% to Rs 2337.87 crore in the year ended March 2017 as against Rs 2184.63 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear Endedn++Mar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var. Sales527.54537.32 -2 2337.872184.63 7 OPM %31.0232.30 -31.6129.94 - PBDT154.73168.25 -8 726.58639.53 14 PBT79.7279.20 1 421.91387.40 9 NP68.6570.04 -2 346.37332.15 4

Powered by Capital Market - Live News